Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: Report of a case

In: Obstetrics & Gynecology · 1993 · vol. 82(4) , pp. 642–644 · doi:10.1097/00006250-199310000-00032 · W4240440374
article OA: closed CC0 ⤵ 7 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

A 50-year-old woman developed extensive tumor-like endometriosis requiring surgery after two years of adjuvant tamoxifen therapy for breast cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Tamoxifen has been used in the adjuvant treatment of breast cancer because of its antiestrogenic effects. However, recent reports have shown it to have estrogenic effects as well. The purpose of this report is to describe a potential association between tamoxifen therapy and endometriosis. Case: A 50-year-old postmenopausal woman who had received 2 years of adjuvant tamoxifen therapy for breast carcinoma developed extensive tumor-like endometriosis necessitating extensive pelvic and intestinal surgery. Conclusion: This case report highlights the need for obstetricians and gynecologists to be familiar with the actions of tamoxifen and its potential complications.(Obstet Gynecol 1993;82:642-4)

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (7)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK